Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ping Mu
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR
Abstract Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by adenosine deaminases acting on RNA (ADARs), is a widespread modification in metazoans. Cumulative evidence has revealed the altered A-to-I editing profiles in cancers, but the underlying mechanism remains unclear. Here, we discover the well-known histone lysine methyltransferase enhancer of zeste homologue 2 (EZH2) as an unexplored ADAR interactor and editing regulator in prostate cancer (PCa).
Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity - Cancer Gene Therapy
Abstract Metastasis, the primary cause of death in lung cancer patients, is facilitated by cytoskeleton remodeling, which plays a crucial role in cancer cell migration and invasion. However, the precise regulatory mechanisms of intracellular trafficking proteins involved in cytoskeleton remodeling remain unclear. In this study, we have identified Rabenosyn-5 (Rbsn) as an inhibitor of filopodia formation and lung cancer metastasis.
ZNF397 Deficiency: A Key Driver of Lineage Plasticity in Prostate Cancer Therapy Resistance - Ping Mu
Read the Full Video Transcript Andrea Miyahira: Hi everyone, I'm Andrea Miyahira here at the Prostate Cancer Foundation, and thank you for joining me today. With me is Dr. Ping Mu, an Associate Professor at UT Southwestern Medical Center. Dr. Mu is discussing his latest paper, "ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity in AR-Targeted Therapy Resistance in Prostate Cancer," which was published in Cancer Discovery. Dr. Mu, thanks for joining me again.
How UBE2J1 Impacts Anti-Androgen Resistance in Prostate Cancer - Ping Mu
Read the Full Video Transcript Andrea Miyahira: Hi, everyone. Thank you for joining us today. I'm Andrea Miyahira here at the Prostate Cancer Foundation. With me today is Dr. Ping Mu, an assistant professor at UT Southwestern Medical Center. He'll be discussing his group's latest paper, "UBE2J1 Is the E2 Ubiquitin-Conjugating Enzyme Regulating Androgen Receptor Degradation and Anti-Androgen Resistance,” which was published in Oncogene. Thank you so much for joining me today, Ping.
ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers
Abstract Cancer cells exhibit phenotypical plasticity and epigenetic reprogramming, which allows them to evade lineage-dependent targeted treatments by adopting lineage plasticity. The underlying mechanisms by which cancer cells exploit the epigenetic regulatory machinery to acquire lineage plasticity and therapy resistance remain poorly understood.
Loss of SYNCRIP Unleashes APOBEC-Driven Mutagenesis, Tumor Heterogeneity and AR-Targeted Therapy Resistance in Prostate Cancer - Ping Mu
Read the Full Video Transcript Andrea Miyahira: Hi everyone. Thank you for joining us today. I'm Dr. Andrea Miyahira at the Prostate Cancer Foundation. Today I'm joined by Dr. Ping Mu, an assistant professor at the UT Southwestern Medical Center to discuss his group's recent paper, Loss of SYNCRIP Unleashes APOBEC Driven Mutagenesis, Tumor Heterogeneity in AR Targeted Therapy Resistance in Prostate Cancer, recently published in Cancer Cell. Thanks for joining me today, Ping.
The Critical Interplay of CAF Plasticity and Resistance in Prostate Cancer
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Application of New High-Energy Expansion Agent in Coal Mine Roadway Excavation
Open AccessArticle by 1, 2, 1, 1,*, 1 and 1 1 College of Safety and Environmental Engineering, Shandong University of Science and Technology, Qingdao 266590, China 2 Hubei Sunvalor Power Source Aerospace Tech Co., Ltd., Xiangyang 441003, China * Author to whom correspondence should be addressed.
Visible and near-infrared driven Yb3+/Tm3+ co-doped InVO4 nanosheets for highly efficient photocatalytic applications
Visible and near-infrared driven Yb3+/Tm3+ co-doped InVO4 nanosheets for highly efficient photocatalytic applications† Kailian Zhang,a Jie Guan,a Ping Mu,a Kai Yang, *ab Yu Xie,c Xiaoxiao Li,a Laixi Zou,*a Weiya Huang,a Changlin Yu *d and Wenxin Dai b Author affiliations * Corresponding authors a School of Chemistry and Chemical Engineering, Jiangxi University of Science and Technology, Ganzhou 341000, Jiangxi, China E-mail: 19979706763@126.com, zoulaixi@jxust.edu.cn Fax: +86-797-8312334...
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Prostate cancer growth is fueled by male hormones called androgens. Drugs targeting the androgen receptor (AR) are initially efficacious, but most tumors eventually become resistant (see the Perspective by Kelly and Balk). Mu et al. found that prostate cancer cells escaped the effects of androgen deprivation therapy through a change in lineage identity.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer
Prostate cancer growth is fueled by male hormones called androgens. Drugs targeting the androgen receptor (AR) are initially efficacious, but most tumors eventually become resistant (see the Perspective by Kelly and Balk). Mu et al. found that prostate cancer cells escaped the effects of androgen deprivation therapy through a change in lineage identity.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ping
Contact Ping, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack